700 related articles for article (PubMed ID: 11146566)
21. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
24. Analysis of parameters affecting engraftment in children undergoing allogeneic BM transplants.
Kletzel M; Haut PR; Olzewski M; Figuerres E
Cytotherapy; 1999; 1(5):417-22. PubMed ID: 20443234
[TBL] [Abstract][Full Text] [Related]
25. Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
Devine SM; Sanborn R; Jessop E; Stock W; Huml M; Peace D; Wickrema A; Yassine M; Amin K; Thomason D; Chen YH; Devine H; Maningo M; van Besien K
Bone Marrow Transplant; 2001 Sep; 28(6):557-62. PubMed ID: 11607768
[TBL] [Abstract][Full Text] [Related]
26. Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation.
Woo KS; Goh RY; Kim SH; Kwon HC; Kim HJ; Lee YH; Han JY
Cytotherapy; 2007; 9(6):555-61. PubMed ID: 17882720
[TBL] [Abstract][Full Text] [Related]
27. Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation.
Beguin Y; Baron F; Fillet G
Haematologica; 1998 Dec; 83(12):1076-81. PubMed ID: 9949624
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34(+) cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell support.
Consolini R; Calleri A; Bengala C; Legitimo A; Conte PF
Haematologica; 2001 Sep; 86(9):959-64. PubMed ID: 11532624
[TBL] [Abstract][Full Text] [Related]
30. Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor cell transplantation.
Ninan MJ; Flowers CR; Roback JD; Arellano ML; Waller EK
Biol Blood Marrow Transplant; 2007 Aug; 13(8):895-904. PubMed ID: 17640593
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of immature reticulocyte and platelet fractions in hematopoietic recovery of allograft patients.
Gonçalo AP; Barbosa IL; Campilho F; Campos A; Mendes C
Transplant Proc; 2011; 43(1):241-3. PubMed ID: 21335197
[TBL] [Abstract][Full Text] [Related]
32. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
33. Dendritic cell recovery after autologous stem cell transplantation.
Damiani D; Stocchi R; Masolini P; Michelutti A; Sperotto A; Geromin A; Skert C; Cerno M; Michieli M; Baccarani M; Fanin R
Bone Marrow Transplant; 2002 Sep; 30(5):261-6. PubMed ID: 12209346
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of erythropoietic/hematopoietic reconstitution after BMT by highly fluorescent reticulocyte counts compares favorably with traditional peripheral blood cell counting.
Kanold J; Bezou MJ; Coulet M; Quainon F; Malpuech G; Travade P; Deméocq F
Bone Marrow Transplant; 1993 Apr; 11(4):313-8. PubMed ID: 7683553
[TBL] [Abstract][Full Text] [Related]
35. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor.
Magro E; Regidor C; Cabrera R; Sanjuán I; Forès R; Garcia-Marco JA; Ruiz E; Gil S; Bautista G; Millán I; Madrigal A; Fernandez MN
Haematologica; 2006 May; 91(5):640-8. PubMed ID: 16670070
[TBL] [Abstract][Full Text] [Related]
36. Analysis of parameters affecting engraftment in children undergoing autologous peripheral blood stem cell transplants.
Figuerres E; Haut PR; Olzewski M; Kletzel M
Bone Marrow Transplant; 2000 Mar; 25(6):583-8. PubMed ID: 10734291
[TBL] [Abstract][Full Text] [Related]
37. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
[TBL] [Abstract][Full Text] [Related]
38. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
[TBL] [Abstract][Full Text] [Related]
39. CD34+ cell responsiveness to stromal cell-derived factor-1alpha underlies rate of engraftment after peripheral blood stem cell transplantation.
Marquez-Curtis LA; Turner AR; Larratt LM; Letcher B; Lee SF; Janowska-Wieczorek A
Transfusion; 2009 Jan; 49(1):161-9. PubMed ID: 18954402
[TBL] [Abstract][Full Text] [Related]
40. Decreased endogenous circulating Steel factor (SLF) levels following allogeneic and autologous BMT: lack of an inverse correlation with post-BMT myeloid engraftment.
Cairo MS; Gillan ER; Weinthal J; Yancik S; van de Ven C; Ho W; Shen V; Buzby JS; Suen Y
Bone Marrow Transplant; 1993 Feb; 11(2):155-61. PubMed ID: 7679598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]